The Net Margin of Adaptimmune Therapeutics PLC (ADAP) is -39.78%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -39.78% |
| 2023-12-31 | -188.90% |
| 2022-12-31 | -609.43% |
| 2021-12-31 | -2570.57% |
| 2020-12-31 | -3285.10% |
| 2019-12-31 | -12247.32% |
| 2018-12-31 | -160.49% |
| 2017-12-31 | -185.41% |
| 2016-12-31 | -504.08% |
| 2015-06-30 | -201.40% |